openPR Logo
Press release

Protagen and Charles River form strategic partnership

10-31-2011 02:14 PM CET | Health & Medicine

Press release from: Protagen AG

Dortmund, Germany, October 28, 2011. Protagen AG, Dortmund, a GMP-certified specialist in the characterization of protein drugs and Charles River Laboratories International, Inc., one of the world leading companies in high-quality research models and preclinical and clinical support services, are pleased to announce a strategic Marketing & Sales alliance.

For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River BPS delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen AG, an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.

Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.

“The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio “, comments Dr. Stefan Müllner, CEO of Protagen AG.

About Protagen AG
Protagen AG (http://www.protagen.com) is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.

Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de

Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund

Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protagen and Charles River form strategic partnership here

News-ID: 198484 • Views:

More Releases from Protagen AG

Protagen and OncoTyrol form strategic alliance to validate the UNIarray® techno …
Dortmund, Germany and New Jersey, USA, June 10, 2009. Protagen AG and the Medical University Innsbruck, Department of Urology, have recently identified autoantigen candidates present in serum of patients with prostate cancer using the proprietary UNIArray® technology platform. In Europe, prostate cancer is the second most frequent lethal malignancy in men. Yearly about 40,000 men die of prostate cancer in the European Union. Current standard of screening for prostate
Protagen meets with FDA
Dortmund, Germany and New Jersey, USA, February 19, 2009. Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips announces that it participated in two meetings with FDA personnel during the week of January 26, 2009. The meetings were intended to provide a detailed introduction to the company’s UNIarray® technology position and its potential use in the development of novel diagnostics for multiple sclerosis
Bayer HealthCare and Protagen sign a contract to evaluate the UNIarray® technol …
Dortmund, Germany and New Jersey, USA, December 3, 2008. Protagen AG announces the closing of a cooperation contract with Bayer HealthCare AG, Leverkusen, Germany, about the evaluation of the UNIarray® technology for discovery of novel biomarkers in atrial fibrillation. Bayer HealthCare is currently investigating atrial fibrillation after heart surgery in a clinical study. A certain number of patients develop this type of cardiac symptoms after surgery. Currently, it is not possible
Winner Consortium “NeuroAllianz” in the BioPharma Competition counts on UNIa …
Dortmund, Germany and New Jersey, USA, October 9, 2008: Protagen AG, a leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein biochips has won the BMBF’s BioPharma competition jointly with consortium “NeuroAllianz”. The twelve project partners will develop therapeutic as well as diagnostic approaches in the field of neurodegenerative diseases from bench to market under the direction of Professor Christa E. Mueller and Professor Alexander Pfeifer. Protagen

All 5 Releases


More Releases for Charles

Charles Paddock Zoo Adds Solar Energy System
The solar energy system was donated and installed last summer by local solar installer, Solarponics. Atascadero, CA, USA -- The Charles Paddock Zoo in Atascadero adds solar energy system as part of their ongoing conservation mission. They join other zoo's including; Cincinnati Zoo, Toledo Zoo, Knoxville Zoo, Saint Louis Zoo, Oakland Zoo, and San Diego Zoo, who have made a similar move to renewable energy. The solar energy system was donated and
Charles Brothers – your #1 choice for Pennsylvania lawyers
United States 10-03-2017. The Charles Brothers gladly provide highly professional and dedicated legal support to people involved in personal injury cases. Dealing with a personal injury matter can be more stressful than any other issue. When anyone experiences a personal injury due to carelessness of another person then the wise decision is to speak to a professional and experienced personal injury lawyer who specializes in this specific field. The personal
CHARLES & KEITH Summer 2016
CHARLES & KEITH SUMMER 2016 draws on a tale of one’s journey to self discovery, a delivery of self expressionism. Pushing forth the idea of self identity, a series of visual narratives portray the dialogues of one’s inner thoughts. In this issue, international style authority Kristina Bazan shares her journey in life as well as her travel stories. Ornate embellishments have been abandoned in pursuit of a
Charles Rutenberg Realty Expands its Commercial Division
Charles Rutenberg Realty is announcing the expansion of its firm by adding approximately 100 Agents who will be directing their efforts towards Commercial Real Estate. They will cover the entire Long Island and New York Metropolitan areas and, if necessary, will be available to complete transactions on a National basis. “We are proud to see our firm grow its Commercial Real Estate business here on Long Island and in the
Charles Rutenberg Realty Adds New Agents
Charles Rutenberg Realty is continuing their success in being one of the nation's fastest-growing Real Estate Agencies with the addition of the following new Agents to the firm: · Vinod Persad and Sanjay Persaud, formerly of Ahmad Realty, Inc. · Robert M. Murphy, formerly of EXIT Realty Action ·
Charles Rutenberg Realty Adds New Agents
Charles Rutenberg Realty is continuing their success in being one of the nation's fastest-growing Real Estate Agencies with the addition of the following new Agents to the firm: · Eileen Appel, formerly with Lynda Baker Realty · Evelyn Gonzalez, formerly with Exceptional Homes RE · Carolita Powell, formerly